HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Israel, O. Articles by Strauss, H. W. Search for Related Content PubMed PubMed Citation Articles by Israel, O. Articles by Strauss, H. W.

PET/CT Quantitation of the Effect of Patient-Related Factors on Cardiac ¹⁸F-FDG Uptake

¹ Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel; ² B. Rappaport School of Medicine, Israel Institute of Technology–Technion, Haifa, Israel; ³ Functional Imaging, General Electric Healthcare Technologies, Tirat Hacarmel, Israel; and ⁴ Division of Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Correspondence: For correspondence or reprints contact: Ora Israel, MD, Department of Nuclear Medicine, Rambam Health Care Campus, Haifa 35254, Israel. E-mail: o_israel{at}rambam.health.gov.il

The effect of multiple patient-related factors on the degree of cardiac ¹⁸F-FDG uptake was assessed. Methods: Five hundred four consecutive patients undergoing routine ¹⁸F-FDG PET/CT studies completed a clinical questionnaire. ¹⁸F-FDG uptake was measured as the mean standardized uptake value within the heart delineated on the CT component of the study. Univariate and multivariate analyses assessed the influence of 51 clinical factors on cardiac ¹⁸F-FDG uptake. Results: On both multivariate and univariate analyses, cardiac ¹⁸F-FDG uptake was significantly lower in diabetics and in patients receiving bezafibrate or levothyroxine. Cardiac ¹⁸F-FDG uptake was significantly higher in men, patients younger than 30 y old, fasting duration of <5 h, patients with heart failure, and those receiving benzodiazepines. Conclusion: Cardiac ¹⁸F-FDG uptake was lower in patients receiving bezafibrate and levothyroxine and higher in patients receiving benzodiazepines. If further confirmed by prospectively designed studies, manipulation of these drugs may represent tools for optimized PET/CT imaging.

Key Words: ¹⁸F-FDG • PET/CT • cardiac uptake • quantitation

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  

This article has been cited by other articles:

				J. J. Fox and H. W. Strauss One Step Closer to Imaging Vulnerable Plaque in the Coronary Arteries J. Nucl. Med., April 1, 2009; 50(4): 497 - 500. [Full Text] [PDF]

				M. P. S. Dunphy, H. Schoder, and H. W. Strauss Radionuclide Techniques for Identifying Vulnerable Plaque J. Nucl. Med., November 1, 2007; 48(11): 1753 - 1755. [Full Text] [PDF]